Haloperidol DecanoateThird Party Manufacturing in India

Haloperidol Decanoate works by binding to and blocking central dopamine D2 receptors within the mesolimbic pathway. It inhibits dopaminergic overactivity to help the body control chronic hallucinations, agitations, and manic behaviors. Unlike short-acting haloperidol solutions, it is formulated in a sesame oil base, allowing for a steady release profile lasting up to four weeks. It is highly effective and well-tolerated for long-term psychological maintenance.

Therapeutic Uses

• Chronic Schizophrenia Management: Provides long-term maintenance for outpatients requiring sustained therapeutic neuroleptic concentrations.
• Psychotic Disorder Maintenance: Prevents psychological relapses and cognitive fragmentation in non-compliant patients.

Why Manufacturers Choose Haloperidol Decanoate

Haloperidol Decanoate third party manufacturing in India commands consistent B2B value because long-acting neuroleptic options are indispensable in public health and institutional psychiatry. This specialized formulation requires non-aqueous filling expertise to ensure zero crystallization. Our partner production facilities offer advanced automated line architectures. Relying on WHO-GMP certified partner locations ensures compliance with global pharmacopeia standards, enhancing your brand presence across multiple regions.